TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -6 | -6 | -47 | -61 | -60 | -29 | -35 |
| P | %wins | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/15/20 21:00 | 12/14/20 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Bertrand William C Jr | X0 | O | COO | P | 144 | 0.6948 | 0 | 207 | 266 | 285 | D | ||||||||||||||
12/21/15 21:35 | 12/17/15 | ARDX | Ardelyx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bertrand William C Jr | CA | D | P | 100 | 20.00 | 3 | 5 | New | 5 | D | -18 | 19 | -7 | 3 | 0 | 11 | -2 | -6 | -6 | -47 | -61 | -60 | -29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |